Back to Authors

Patel, P.

Mayo Clinic

Clinical Director Acerta Pharma South San Francisco United States

Citations 1

ACALABRUTINIB PLUS PEMBROLIZUMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A PHASE 1/2 STUDY

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 327-328

10.1002/hon.139_2630